Hermetica Superfood Encyclopedia
Southernwood (Artemisia abrotanum) is a European herb containing bioactive compounds like ascaridole and essential oils. The plant demonstrates antimicrobial and anti-inflammatory properties through modulation of immune pathways, though clinical evidence remains limited.


Southernwood (Artemisia abrotanum) is a perennial herb in the Asteraceae family, native to southern Europe and temperate Asia, now widely cultivated globally. The aerial parts, particularly flowering tops, are harvested and processed via steam distillation for essential oils or ethanolic extraction for tinctures and herbal preparations.
No human clinical trials, RCTs, or meta-analyses specific to Artemisia abrotanum were identified in the available research. While chemical characterization studies exist (via GC-MS), they focus on composition rather than clinical outcomes, with no PMIDs linked to human efficacy studies.

No clinically studied dosage ranges are available due to absence of human trials. Traditional forms include essential oil (steam distilled), ethanolic extracts, tinctures (CAS 89957-58-4), and herbal preparations from aerial parts, but without standardized doses established through research. Consult a healthcare provider before starting any new supplement.
Southernwood (Artemisia abrotanum) is used as an aromatic herb rather than a food crop, so comprehensive macronutrient profiling is limited. Available phytochemical analyses indicate the following: **Essential oil (0.3–1.5% of dry weight):** dominated by 1,8-cineole (eucalyptol, ~15–30% of oil), camphor (~5–15%), β-pinene (~3–10%), davanone derivatives (~5–20%), and smaller amounts of α-thujone, β-thujone, and linalool. Ascaridole has been reported in some chemotypes but is not universally present and concentrations vary significantly by provenance. **Flavonoids:** rutin (quercetin-3-O-rutinoside, reported at ~0.2–0.8% dry weight in aerial parts), isorhamnetin glycosides, and lesser amounts of apigenin and luteolin derivatives; these contribute modest antioxidant capacity. **Phenolic acids:** chlorogenic acid and caffeic acid derivatives are present in aqueous and hydroalcoholic extracts, typically in the range of 1–3 mg/g dry weight collectively. **Coumarins:** scopoletin and umbelliferone have been identified in trace to low concentrations. **Sesquiterpene lactones:** characteristic of the Artemisia genus, including artabsin and absinthin-type compounds in low concentrations; these may contribute to bitter tonic properties but also raise toxicity concerns at high doses. **Macronutrients:** when consumed as a dried herb or tea, caloric contribution is negligible; crude protein ~8–12% of dry weight (typical for Artemisia aerial parts), crude fiber ~15–25% dry weight, and ash (mineral) content ~6–10% dry weight. **Minerals (approximate, per 100 g dry herb):** potassium (~1,500–2,500 mg), calcium (~800–1,500 mg), magnesium (~200–400 mg), iron (~15–40 mg), manganese (~5–15 mg), and zinc (~3–7 mg); these values are extrapolated from related Artemisia species and limited direct analyses. **Vitamins:** no reliable quantitative data specific to A. abrotanum; trace amounts of vitamin C and provitamin A (β-carotene) are plausible based on genus-level data but unconfirmed. **Bioavailability notes:** essential oil constituents (1,8-cineole, camphor) are readily absorbed via oral and inhalation routes; flavonoid glycosides such as rutin have relatively low oral bioavailability (~15–20%) due to the need for intestinal hydrolysis to release the aglycone quercetin; sesquiterpene lactones are lipophilic and moderately well-absorbed but may be hepatotoxic at elevated doses; mineral bioavailability from dried herb matrices may be reduced by tannin and fiber content. Overall, southernwood is valued for its bioactive volatile and phenolic compounds rather than as a nutritional source.
Southernwood's primary bioactive compound ascaridole disrupts microbial cell membranes and parasitic enzyme systems. Essential oils containing camphor and thujone modulate inflammatory cytokine production through NF-κB pathway inhibition. The volatile compounds also demonstrate anthelmintic activity by interfering with parasitic nervous system function.
Human clinical trials for southernwood are currently unavailable, limiting evidence quality to preclinical studies. Laboratory research on related Artemisia species suggests antimicrobial activity against various bacterial and fungal strains. Traditional use documentation spans centuries for digestive complaints and parasitic infections. Current evidence classification remains at preliminary level requiring controlled human studies for validation.
Southernwood contains thujone, which may cause neurotoxicity in high doses and should be avoided during pregnancy and breastfeeding. The herb may interact with anticoagulant medications due to potential blood-thinning effects. Allergic reactions are possible in individuals sensitive to Asteraceae family plants. Long-term safety data is insufficient, warranting caution with extended use.